Protein engineering studies on C1r and C1s.
1. C1r and C1s cDNAs were placed downstream the strong polyhedrin promoter in the Autographa californica nuclear polyhedrosis virus and the recombinant proteins were expressed in insect cells, in biologically active form. The yield of expression is high enough to get recombinant components for chemical and functional studies (5 micrograms/ml cell culture supernatant). 2. The biological activity and the post-translational modifications of the recombinant subcomponents were checked. The rC1r and rC1s proved to be biologically active in the hemolytic assay, although their glycosylations were different compared to that of the serum proteins. The insect cells are able to beta-hydroxylate the Asn residue of the EGF domain in the C1r but with a low efficiency. It is clear now, that this post-translational modification does not play a role in the Ca2+ dependent C1r-C1s interaction. 3. Two deletion mutants of C1r cDNA were constructed in order to clarify the role of domain I and II. The results show that both, domain I, and II are absolutely necessary for the tetramer formation and both have a regulatory role in the autoactivation. The autoactivation of the mutants is accelerated significantly. 4. Hybrid cDNA constructions were also made, and one of them was expressed. In the C1s alpha R hybrid the C1s alpha part cannot dimerize in presence of Ca2+, but it can form a tetramer with C1r2, that can bind to C1q. This observation indicates that the function of the C1s alpha part in the hybrid is modulated by the C1r part (gamma B) of the molecule. 5. In order to control the autoactivation process point mutant cDNAs were constructed through altering the Arg-Ile bond in the catalytic domain of the C1r. The Gln-Ile construction is a stable zymogen while the Arg-Phe mutant has a lower rate of autoactivation. These results do justify our approach of using domain-domain interchange, domain deletion and point mutations in combination, to reveal the structural background of C1 function at intramolecular level.
Závodszky
P
P
Institute of Enzymology, Hungarian Academy of Sciences, Budapest.
Gál
P
P
Cseh
S
S
Schumaker
V N
VN
D000818:Animals; D016367:Baculoviridae; D002460:Cell Line; D015923:Complement C1r / Q000096:biosynthesis* / Q000737:chemistry; D003173:Complement C1s / Q000096:biosynthesis* / Q000737:chemistry; D006031:Glycosylation; D006801:Humans; D007313:Insecta; D016296:Mutagenesis; D017354:Point Mutation; D011487:Protein Conformation; D015202:Protein Engineering; D011499:Protein Processing, Post-Translational; D017433:Protein Structure, Secondary; D011994:Recombinant Proteins / Q000096:biosynthesis* / Q000737:chemistry; D012697:Serine Endopeptidases / Q000737:chemistry; D014162:Transfection
D011994:Recombinant Proteins; D012697:Serine Endopeptidases; D015923:Complement C1r; D003173:Complement C1s